Tamara Marconi
- Lymphoma Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Platelet Disorders and Treatments
- Multiple and Secondary Primary Cancers
- Colorectal and Anal Carcinomas
- Blood groups and transfusion
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Viral-associated cancers and disorders
- Clinical Laboratory Practices and Quality Control
Melbourne Health
2024
Eastern Health
2024
Box Hill Hospital
2023
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare cancer, and large international cooperative efforts are needed to evaluate the significance of clinical risk factors immunoarchitectural patterns (IAPs) for all stages pediatric adult patients with NLPHL.
Background: Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare cancer, and large studies evaluating outcomes for patients with scoring of immunoarchitectural patterns (IAPs) are needed. We performed an international study pediatric adult all stages NLPHL. Methods: Thirty-seven centers participated in the Global nLPHL One Working Group to retrospectively identify NLPHL cases from 1992-2021. measured progression-free survival (PFS), overall (OS), transformation rate,...